James Jones, MD
Pulmonary Disease · Jackson, MSNPI 1770577561
Payments from drug & device makers
Across 157 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Insmed, Inc.$192
- Actelion Pharmaceuticals US, Inc.$177
- Grifols USA, LLC$116
- Inari Medical, Inc.$102
- Mylan Specialty L.p.$99
- plus $514 from 14 others
What the payments were for
- Food & beverage$2,43799%
- Education$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 86 | $1,253 |
| Insmed, Inc. | 12 | $192 |
| Actelion Pharmaceuticals US, Inc. | 9 | $177 |
| Grifols USA, LLC | 7 | $116 |
| Inari Medical, Inc. | 7 | $102 |
| Mylan Specialty L.p. | 6 | $99 |
| Genentech USA, Inc. | 6 | $95 |
| AbbVie | 4 | $88 |
| Ambu Inc. | 4 | $52 |
| Boehringer Ingelheim | 3 | $50 |
| Merck | 2 | $41 |
| Philips North America LLC | 1 | $28 |
| Gilead | 2 | $28 |
| AstraZeneca | 2 | $25 |
| United Therapeutics Corporation | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Sanofi | 1 | $15 |
How this compares
$2,453 in reported general payments places this provider in the 35th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Jackson
- Demondes HaynesJackson$809K
- Michal SenitkoJackson$355K
- Andrew WilhelmJackson$164K
- Maria RappaiJackson$45K
- Raymond PortisJackson$39K
- Kimberly DobbsJackson$35K
- George AbrahamJackson$23K
- Arash SamarghandiJackson$19K
- Richard WellsJackson$19K
- Rajesh PatelJackson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.